![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/381 | (2006.01) |
A61K 31/381 | (2013.01) | ||
A61K 31/519 | (2006.01) | ||
A61K 31/519 | (2013.01) | ||
C07D 487/14 | (2006.01) | ||
A61P 35/00 | (2018.01) | ||
A61P 35/00 | (2006.01) |
(11) | Number of the document | 3565558 |
(13) | Kind of document | T |
(96) | European patent application number | 18736115.9 |
Date of filing the European patent application | 2018-01-05 | |
(97) | Date of publication of the European application | 2019-11-13 |
(45) | Date of publication and mention of the grant of the patent | 2023-12-06 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2018/012675 |
Date | 2018-01-05 |
(87) | Number | WO 2018/129387 |
Date | 2018-07-12 |
(30) | Number | Date | Country code |
201762443588 P | 2017-01-06 | US |
(72) |
STRUM, Jay, C. , US
THATCHER, Gregory, R. , US
XIONG, Rui , US
ZHAO, Jiong , US
TONETTI, Debra, A. , US
|
(73) |
G1 Therapeutics, Inc. ,
79 TW Alexander Drive 4501
Research Commons
Suite 100
Research Triangle Park, NC 27709,
US
The Board of Trustees of the University of Illinois , 352 Henry Administration Building 506 South Wright Street, Urbana, IL 61801, US |
(54) | COMBINATION THERAPY WITH A SERD COMPOUND AND A CDK4/6 INHIBITOR FOR THE TREATMENT OF CANCER |
COMBINATION THERAPY WITH A SERD COMPOUND AND A CDK4/6 INHIBITOR FOR THE TREATMENT OF CANCER |